HealthNational

Moderna Says COVID-19 Vaccine is 94.5% Effective; 2nd Vaccine to Show Success

Moderna said Monday that early data show its coronavirus vaccine candidate is 94.5% effective in preventing infection — the second major drugmaker in as many weeks to tout a potential vaccine with an efficacy rate over 90%.

The company plans to apply to the Food and Drug Administration for approval of its vaccine after more safety data has been collected, CNN reported.

Moderna’s trials consisted of 15,000 study participants who were given a placebo, which is a shot of saline that has no effect. Over several months, 90 of those participants got the coronavirus.

Another 15,000 participants were given the vaccine, and five of them developed COVID-19, CNN reported. Among the placebo group, 11 became seriously ill, but none of the participants who received the vaccine became severely ill.

Moderna’s announcement comes after Pfizer, another one of several companies working on a vaccine, said last week that its vaccine candidate has an efficiency rate of more than 90%, calling it the “greatest medical advance in the last 100 years.”

As of Monday, the U.S. has approximately 11.1 million coronavirus cases and 247,000 related deaths — both tops globally — according to a Johns Hopkins University tracker.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker